DirectSens’ Market-Leading LactoSens ® Biosensor Technology Acquired by Kerry Group P.L.C.
DirectSens, a pioneer in next generation biosensor technology, announces the acquisition of its LactoSens® technology by Kerry Group, a global leader in taste and nutrition. The acquisition of LactoSens® reflects DirectSens’ success in developing end-to-end biosensor solutions and represents a move by Kerry Group to complement its offering in lactase enzymes. As an indispensable analytical tool, LactoSens® will work alongside Kerry Group’s ingredient solutions, enabling a more integrated offering for food manufacturers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241105399369/en/
LactoSens®, Industry Gold Standard Biosensor Kit. Developed and manufactured by DirectSens in Vienna, AUSTRIA, © DirectSens GmbH 2024
“We’re excited to bring LactoSens® into Kerry Group’s portfolio to add a new element to our offering, as we fully integrate LactoSens® into our broader solutions for the food and beverage industry.” — Ronan Moloney, Vice President Enzymes, Kerry Group
Proven track record with global success of LactoSens®
Since its introduction, 8 years ago, LactoSens® has become the industry’s preferred solution for fast, accurate, and cost-effective lactose detection. It is widely used in food and beverage manufacturing, enabling producers to meet stringent regulatory requirements while running their processes efficiently. Its real-time analysis capabilities give manufacturers a competitive edge, solidifying LactoSens® as a market leader.
DirectSens’ Market-Leading Enzyme Engineering and BioSensor technology
For DirectSens, this acquisition proves the market value of its biosensor technology. “This deal underscores the quality of our biosensor technology and manufacturing capabilities. We will continue to execute on our vision to develop and deliver fast and precise biosensor solutions for key analytes to the global marketplace.” said Dr. Christoph Sygmund, CEO of DirectSens.
As the trusted contract manufacturer, DirectSens will continue to ensure the high-quality production of LactoSens®, upholding the product’s established market reputation. This acquisition reinforces DirectSens’ position as a key innovator in the biosensor industry. Excited by this success, the DirectSens team, with its dedicated and passionate individuals, is looking forward to continuing to create new products such as OatSens®, LactaZyme®, XPressGT®, and to foster collaborations with valued partners.
About DirectSens
DirectSens was founded in 2013 in Vienna, Austria, as a biotech company. Specializing in the development of biosensors, DirectSens provides innovative bioanalytical solutions. Press release.
About Kerry Group
Kerry Group is a world leader in taste and nutrition, serving the food, beverage, and pharmaceutical markets. With a commitment to innovation, Kerry Group helps its customers create sustainable, delicious, and healthy products for consumers worldwide. See related Press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241105399369/en/
Contacts
Gina Gazzari office@directsens.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant Digital Technologies Hosts Trust Bridge Forum at Hong Kong Fintech Week 2024 and Unveils "Dual Chains and One Bridge" Solution6.11.2024 04:48:00 CET | Press Release
Ant Digital Technologies hosted the Trust Bridge Forum at Hong Kong Fintech Week, bringing together key industry leaders and experts to discuss the opportunities and challenges presented by real-world asset (RWA) tokenization. Mr. George Chou, Chief Fintech Officer of the Hong Kong Monetary Authority (HKMA), delivered the opening remarks, highlighting HKMA's commitment to driving fintech innovation, particularly through initiatives like Project Ensemble.“The HKMA recognise that CBDCs have the potential to unlock unrealised economic value by transforming the ways we transact and the systems we transact on,” stated Mr. Chou. “Collaboration between the public and private sectors is crucial to success. We look forward to continuing collaboration with the world and all relevant industry participants.” Dr. Ying Yan, Chief Scientist at Ant Digital Technologies, provided insights into the evolution of Web3 technology and AntChain’s trusted digital-twin technology which is centered around block
IFF Reports Third Quarter 2024 Results5.11.2024 22:37:00 CET | Press Release
IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2024. Management Commentary “We are pleased to report a strong performance in the third quarter, with growth across all business segments,” stated IFF CEO Erik Fyrwald. “Market recovery off prior year lows and our global team's passion to address the needs of our customers drove notable volume recovery in every division. This achievement, coupled with our focus on productivity, has resulted in significant bottom-line improvement compared to the same period last year. Taking into account our strong performance in the third quarter and our continued cautiously optimistic outlook for the fourth quarter, we are increasing our full year 2024 financial guidance. We are making solid progress but have a lot of exciting work ahead of us to unleash the full potential of IFF.” Third Quarter 2024 Consolidated Financial Results Reported net sales for the third quarter were $2.93 billion, an increase of 4% versus th
Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award5.11.2024 19:17:00 CET | Press Release
Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, and Response Plus Medical Services (RPM), the largest pre-hospital care and emergency medical services provider in the region, have jointly launched the $1 million Human Energy Health and Wellbeing Award at ADIPEC 2024 to boost workplace wellness across the global Energy sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241105689488/en/ Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award (Photo: AETOSWire) The global energy sector has made significant strides in prioritising the health and wellbeing of its workforce. Building on this, Dr. Shamsheer Vayalil, Founder & Chairman – Burjeel Holdings, and Omran Al Khoori, Chairman – RPM Holding, announced the award during ADIPEC 2024, encouraging CEOs from major global energy organisations to further advance wellbeing across the industry. The award fo
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 20245.11.2024 15:05:00 CET | Press Release
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Bruton’s tyrosine kinase (BTK) inhibitor BRUKINSA® (zanubrutinib), at the 66th ASH Annual Meeting and Exposition in San Diego, December 7-10. BeiGene has 21 abstracts accepted at ASH 2024, with four selected for oral presentation. “In the five years since its initial approval, BRUKINSA has become a standard of care for patients facing many B-cell malignancies, and our data featured at ASH demonstrated how long-term follow-up of treatment with BRUKINSA elicited deep and durable responses, including in patients with chronic lymphocytic leukemia and Waldenström’s macroglobulinemia,” said Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology at BeiGene. “BRUKINSA is just the starting point – pipeline data for our BTK degrader BGB-16673 and BCL2 inhibitor sonrotoclax showcase our contin
Technology Holdings Has Expanded Operations into Brazil, Driving Growth in Latin America5.11.2024 13:35:00 CET | Press Release
Technology Holdings (TH), an award-winning global boutique investment bank with a track record of closing transactions in 24 countries, proudly announces its strategic expansion into Brazil, leveraging digital transformation within one of Latin America’s largest economies. This move significantly strengthens Technology Holdings’ presence in the rapidly growing Latin American market, enabling the firm to play a vital role in the region's expanding M&A landscape. According to Dealogic, M&A deals totaling $35 billion have been announced, reflecting a 56% increase compared to the same period last year. As companies increasingly look to consolidate and expand, Technology Holdings is uniquely positioned to provide strategic guidance and facilitate successful transactions. “The expansion into Brazil represents an exciting opportunity for us to deepen our relationships within this vibrant market,” said Edoardo Freschet, Head of Latin America at Technology Holdings. “The quality of talent and t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom